Literature DB >> 1448488

Distinguishing effects of cocaine i.v. and SC on mesoaccumbens dopamineand serotonin release with chloral hydrate anesthesia.

P A Broderick1.   

Abstract

The effect of i.v. cocaine (0.5 and 1.0 mg/kg) was studied on synaptic concentrations of dopamine (DA) and serotonin [5-hydroxytryptamine (5-HT)] in the mesoaccumbens nerve terminal, the nucleus accumbens (NAcc), in chloral hydrate-anesthetized, male Sprague-Dawley rats (Rattus norvegicus) with in vivo electrochemistry (voltammetry). In further in vivo voltammetric studies, the effects of SC cocaine on synaptic concentrations of DA and 5-HT were studied in the chloral hydrate-anesthetized paradigm in two neuroanatomic substrates, NAcc and mesoaccumbens somatodendrites, the ventral tegmental area (VTA-A10), in a dose-response fashion (10, 20, and 40 mg/kg) in six separate studies. Moreover, in two additional in vivo voltammetric studies, again using the chloral hydrate-anesthetized paradigm, the impulse flow blocker, gamma-butyrolactone (gamma-BL) (750 mg/kg, IP), was studied alone and in combination with SC cocaine (20 mg/kg) to determine whether or not cocaine can act by presynaptic releasing mechanisms for DA and 5-HT. The results show that IV cocaine concurrently and significantly increased DA and 5-HT release in the NAcc (p < 0.001, p < 0.0005, respectively) at both doses tested. Moreover, IV cocaine effects on DA and 5-HT release were significantly and positively correlated (p < 0.01). On the other hand, SC cocaine concurrently and significantly decreased DA and 5-HT release in NAcc (p < 0.0001) and VTA (p < 0.0001) at each separate dose tested. SC cocaine effects on DA and 5-HT release were significantly and positively correlated across dose and neuroanatomic substrate (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448488      PMCID: PMC7133184          DOI: 10.1016/0091-3057(92)90427-h

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  45 in total

1.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

Authors:  A DAHLSTROEM; K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1964

2.  Differences in the pharmacokinetics of cocaine in naive and cocaine-experienced rats.

Authors:  H T Pan; S Menacherry; J B Justice
Journal:  J Neurochem       Date:  1991-04       Impact factor: 5.372

3.  The efferent connection of the nucleus raphe dorsalis.

Authors:  E T Pierce; W E Foote; J A Hobson
Journal:  Brain Res       Date:  1976-04-30       Impact factor: 3.252

4.  Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin.

Authors:  A S Freeman; B S Bunney
Journal:  Brain Res       Date:  1987-03-03       Impact factor: 3.252

5.  Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine.

Authors:  B Moghaddam; B S Bunney
Journal:  Synapse       Date:  1989       Impact factor: 2.562

6.  Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

Authors:  E Carboni; A Imperato; L Perezzani; G Di Chiara
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

7.  Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue.

Authors:  S B Ross; A L Renyi
Journal:  Eur J Pharmacol       Date:  1969-09       Impact factor: 4.432

8.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat.

Authors:  E C Azmitia; M Segal
Journal:  J Comp Neurol       Date:  1978-06-01       Impact factor: 3.215

9.  Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow.

Authors:  J R Walters; R H Roth
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

10.  Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats.

Authors:  D C Roberts; G F Koob
Journal:  Pharmacol Biochem Behav       Date:  1982-11       Impact factor: 3.533

View more
  11 in total

1.  The dopamine antagonist cis-flupenthixol blocks the expression of the conditioned positive but not the negative effects of cocaine in rats.

Authors:  Jennifer M Wenzel; Zu-In Su; Kerisa Shelton; Hiram M Dominguez; Victoria A von Furstenberg; Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2013-09-05       Impact factor: 3.533

Review 2.  Methodological considerations in rat brain BOLD contrast pharmacological MRI.

Authors:  C A Steward; C A Marsden; M J W Prior; P G Morris; Y B Shah
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

3.  Dose-dependent characterization of the rewarding and stimulant properties of cocaine following intraperitoneal and intravenous administration in rats.

Authors:  L E O'Dell; T V Khroyan; J L Neisewander
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

4.  5-HT3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration.

Authors:  G R King; Z Xue; C Calvi; E H Ellinwood
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

5.  Antagonism of cocaine's stimulant effects on local cerebral glucose utilization by the preferential autoreceptor antagonist (+)-AJ 76.

Authors:  B L Casey; C A Ray; M F Piercey
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal.

Authors:  P A Broderick; O Hope; P Jeannot
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1998-02       Impact factor: 5.067

7.  Novel research translates to clinical cases of schizophrenic and cocaine psychosis.

Authors:  João V Nunes; Patricia A Broderick
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

8.  Neuromolecular Imaging Shows Temporal Synchrony Patterns between Serotonin and Movement within Neuronal Motor Circuits in the Brain.

Authors:  Patricia A Broderick
Journal:  Brain Sci       Date:  2013-06-21

9.  Sex-specific brain deficits in auditory processing in an animal model of cocaine-related schizophrenic disorders.

Authors:  Patricia A Broderick; Taylor Rosenbaum
Journal:  Brain Sci       Date:  2013-04-10

10.  Ibogaine modulates cocaine responses which are altered due to environmental habituation: in vivo microvoltammetric and behavioral studies.

Authors:  P A Broderick; F T Phelan; F Eng; R T Wechsler
Journal:  Pharmacol Biochem Behav       Date:  1994-11       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.